March 12, 2012

Drug maker Watson Pharmaceuticals has started a late-stage trial of a drug made to treat benign tumors of the uterus, the company said Monday.

December 9, 2011

Diplomat Specialty Pharmacy has signed an agreement with a provider of acquisition and management services for oral cancer drugs that the companies said would allow for better access to the drugs and related programs.

November 21, 2011

A drug made by Amgen delayed the spread of prostate cancer to the bones in men with the disease and prolonged the survival of men with the condition, according to results of a late-stage clinical trial.

November 16, 2011

The Food and Drug Administration has approved a new drug for treating a rare bone disease, the agency said Wednesday.

November 7, 2011

The Food and Drug Administration has approved a drug made by Bristol-Myers Squibb for treating head and neck cancer, the agency said Monday.

October 10, 2011

Giant Food Stores is marking National Breast Cancer Awareness Month by donating more than $25,000 to organizations that address the disease, the Royal Ahold-owned supermarket chain said.

September 26, 2011

Kroger has committed $3 million in donations for local breast cancer initiatives across the country to support National Breast Cancer Awareness month in October, the grocer announced Monday.

September 14, 2011

My Girls Cream (formerly known as My Girls Radiation Cream) is now available at select pharmacies, oncology boutiques and post-surgery specialty retailers, the manufacturer announced on Wednesday.

September 12, 2011

The Food and Drug Administration is reorganizing its division for regulating cancer drugs, the agency said Monday.

August 18, 2011

Acai berry, cumin, herbal tea, turmeric and long-term use of garlic may negatively impact chemotherapy treatment, according to a new report released Wednesday that originally was presented at the American Society of Clinical Oncology meeting in Chicago this summer.

August 16, 2011

Kroger banners Ralphs and Food 4 Less have both announced fundraising campaigns to benefit Susan G. Komen for the Cure affiliates in California.

August 1, 2011

New guidelines that will ensure women receive preventive health services at no additional cost were announced Monday by the Department of Health and Human Services.

July 12, 2011

The Food and Drug Administration has granted orphan drug designation to a cancer treatment in mid-stage development made by German drug maker 4SC, the company said Tuesday.

June 2, 2011

Bristol-Myers Squibb will collaborate with Roche to investigate the use of a combination of the companies’ drugs in patients with a deadly form of skin cancer.

May 23, 2011

The Food and Drug Administration has approved a Pfizer drug for treating pancreatic tumors.

May 23, 2011

Prince of Peace Enterprises on Monday announced its sponsorship of the 2011 Susan G. Komen Race for the Cure Global, taking place in Washington, D.C., June 4 at the Capitol Mall in support of its external analgesic Tiger Balm.

May 11, 2011

Genentech is seeking approval for a new drug to treat skin cancer, the company said Wednesday.

April 25, 2011

Anglo-Swedish drug maker AstraZeneca has made the drug vandetanib available to certain thyroid cancer patients.

April 13, 2011

A Food and Drug Administration expert panel has given a favorable vote to a drug made by Pfizer for tumors, Pfizer said Tuesday.

April 6, 2011

Breast cancer survivors who experience large weight gain have an increased risk of death after diagnosis, according to research released Tuesday by scientists at the Kaiser Permanente Division of Research in Oakland, Calif.

March 25, 2011

The Food and Drug Administration has approved a new treatment for late-stage skin cancer, the agency said Friday.

January 3, 2011

3Rx Skin Therapy has announced the introduction of a new skin care line to help repair and rejuvenate skin damaged by such cancer treatments as chemotherapy and radiation, and other dry skin issues caused by medical conditions.

December 21, 2010

Abbott has made a pact with a biopharmaceutical company to develop new cancer treatments by making small-molecule inhibitors.

December 16, 2010

A subsidiary of Watson Pharmaceuticals has entered a licensing agreement with a subsidiary of Hungarian drug maker Richter to develop and market a drug for uterine fibroids, the two companies said Thursday.